In addition, the PDCL3 high subgroup had significantly higher immune, stromal and ESTIMATE scores (Figure 5D), which also indirectly implied the possible influence of high PDCL3 expression on remodeling the immune microenvironment during glioma development. This evidence concerns the gene PDCL3 and central nervous system cancer.